Central nervous system involvement in relapsed acute promyelocytic leukemia

Pediatric Blood and Cancer

Volumn 53, Issue 2, 2009, Pages 235-236

  Kaspers, Gertjan ^a   Gibson, Brenda ^b   Grimwade, David ^c   Pession, Andrea ^d   Smith, Owen ^e   Testi, Anna Maria ^f  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d Clinica Pediatrica   (Italy)

^e OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ARSENIC TRIOXIDE; CYTARABINE; GEMTUZUMAB OZOGAMICIN; RETINOIC ACID; ANTINEOPLASTIC AGENT;

BLEEDING; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL PROTOCOL; DISEASE COURSE; HUMAN; LETTER; LUMBAR PUNCTURE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROPHYLAXIS; RECURRENT DISEASE; RELAPSE; RISK FACTOR; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL TRIAL; INTRASPINAL DRUG ADMINISTRATION; NOTE; PATHOLOGY; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CLINICAL TRIALS AS TOPIC; HUMANS; INJECTIONS, SPINAL; LEUKEMIA, PROMYELOCYTIC, ACUTE; NEOPLASM RECURRENCE, LOCAL;

EID: 67649996038     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22024     Document Type: Letter

References (4)

1. Chow J, Feusner J. Isolated central nervous system recurrence of acute promyelocytic leukaemia in children. Pediatr Blood Cancer 2009;52:11-13.
2. Evans GD, Grimwade DJ. Extramedullary disease in acute promyelocytic leukemia. Leuk Lymphoma 1999;33:219-229. (Pubitemid 29196859)
3. Sanz MA, Grimwade D, Tallman MS, et al. Management of acute promyelocytic leukemia: Recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2009;113:1875-1891.
4. Testi AM, Biondi A, Lo Coco F, et al. GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood 2005;106:447-453. (Pubitemid 40981236)